NCT00717522View on ClinicalTrials.gov

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 1, 2008

Primary Completion Date

January 1, 2009

Study Completion Date

January 1, 2009

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Pomalidomide

Trial Locations (3)

68114

Nebraska Methodist Hospital, Omaha

83814

Kootenai Cancer Center, Coeur d'Alene

90403

Sarcoma Oncology Center, Santa Monica

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY